Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy

Brachytherapy ◽  
2016 ◽  
Vol 15 (6) ◽  
pp. 774-779 ◽  
Author(s):  
Shahram Mashouf ◽  
Habib Safigholi ◽  
Tomas Merino ◽  
Abraam Soliman ◽  
Ananth Ravi ◽  
...  
2019 ◽  
Vol 46 (9) ◽  
pp. 3961-3973
Author(s):  
William T. Hrinivich ◽  
Seyoun Park ◽  
Yi Le ◽  
Daniel Y. Song ◽  
Junghoon Lee

2009 ◽  
Vol 92 ◽  
pp. S58
Author(s):  
J-F. Carrier ◽  
M. Brunet-Benkhoucha ◽  
D. Béliveau-Nadeau ◽  
D. Taussky ◽  
D. Donath

2016 ◽  
Vol 41 (4) ◽  
pp. 290-295 ◽  
Author(s):  
Rhian Siân Davies ◽  
Teresa Perrett ◽  
Jane Powell ◽  
Jim Barber ◽  
Jacob Tanguay ◽  
...  

Brachytherapy ◽  
2019 ◽  
Vol 18 (6) ◽  
pp. 863-874 ◽  
Author(s):  
Reyhaneh Nosrati ◽  
William Y. Song ◽  
Matthew Wronski ◽  
Ana Pejović-Milić ◽  
Gerard Morton ◽  
...  

2018 ◽  
Vol 64 (1) ◽  
pp. 79-83
Author(s):  
Vladimir Solodkiy ◽  
Andrey Pavlov ◽  
Aleksey Tsybulskiy ◽  
Anton Ivashin

Introduction. One of the main problems of modem on-courology is treatment for prostate cancer of intermediate and high risk of progression. Modern radiotherapy in this category of patients has an advantage over surgical methods of treatment. One way to improve the effectiveness of radiotherapy is to escalate the dose in the prostate gland. For this purpose a combination of brachytherapy and remote radiotherapy is used. This combination allows increasing the dose of radiation, thereby providing better local control, reducing complications from neighboring organs. Purpose of the study. To conduct a comparative analysis of efficacy and safety of radical treatment of patients with prostate cancer at medium and high risk of progression using a combination of high and low dose rate brachytherapy with external beam radiotherapy. Materials and methods. 107 patients with prostate cancer of the group of medium and high risk of progression combined treatment (brachytherapy with external beam radiotherapy) was conducted. 53 patients underwent combined treatment (HDR-brachytherapy and external beam radiotherapy). 54 patients underwent combined treatment (LDR-brachytherapy and external beam radiotherapy). The observation period was 5 years. Conclusion. In a comparative analysis in groups of combined radiotherapy with the use of high-dose and low-dose-rate brachytherapy, the same effectiveness of immediate and long-term results of treatment was demonstrated. A significant reduction in early and late toxic reactions in patients with high-power brachytherapy has been demonstrated.


2020 ◽  
Vol 40 (11) ◽  
pp. 6443-6456
Author(s):  
NAOYUKI OGASAWARA ◽  
MAKOTO NAKIRI ◽  
HIROFUMI KUROSE ◽  
KOSUKE UEDA ◽  
KATSUAKI CHIKUI ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sota Tanaka ◽  
Tadatoshi Kinouchi ◽  
Tsuguru Fujii ◽  
Tetsuji Imanaka ◽  
Tomoyuki Takahashi ◽  
...  

An amendment to this paper has been published and can be accessed via a link at the top of the paper.


2004 ◽  
Vol 51 (6) ◽  
pp. 3172-3177 ◽  
Author(s):  
M.R. Shaneyfelt ◽  
J.R. Schwank ◽  
D.M. Fleetwood ◽  
R.L. Pease ◽  
J.A. Felix ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document